EBM Focus

Considerations from a primary care perspective about how to apply the ACC/AHA dyslipidemia guideline recommendations in everyday clinical practice.

ACC/AHA lipid guidelines now emphasize lifetime ASCVD risk management, with updated recommendations on who to screen and when, how to use the PREVENT score, treatment thresholds, LDL‑C goals, and flexible use of nonstatin therapies.

The largest randomized trial of leucovorin in children with autism spectrum disorder was retracted, representing a substantial crack in the already weak foundation of evidence supporting the use of this trending treatment.

The EBSCO clinical decision support tools DynaMed/DynaMedex, Dynamic Health, and DynaMed Decisions are used by millions of clinicians across the world. Learn about some of the top searches, specialties, and tools used in 2025.

The historical lack of analgesia for office-based uterine and cervical procedures has been a hot topic in the media lately. Here’s why. (3 minute read)

A recent study published in JAMA Dermatology finds an increased risk of developing psoriasis in patients taking dupilumab for moderate-to-severe eczema. Is this adverse event a big deal? Find out more from our EBM Focus team. [4 minute read]

Mild asthma may never look the same again. An albuterol-budesonide combination inhaler on an as-needed basis could reduce severe exacerbation and the need for systemic steroids compared to albuterol alone.

A new diagnostic framework for obesity could radically change how clinicians manage persons with elevated BMI.

Is HPV home testing for cervical cancer screening ready for prime time? Read about new research in cervical cancer screening from the Editors at DynaMed.